WHWK
Whitehawk Therapeutics, Inc.
NASDAQ: WHWK · HEALTHCARE · BIOTECHNOLOGY
$4.04
-2.18% today
Updated 2026-04-29
Market cap
$194.92M
P/E ratio
—
P/S ratio
27.28x
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F6.0
Quality
B2.0
Profitability
F5.0
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$6.25
+54.70%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at -288.30%
- Negative free cash flow $-17.23M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $15.22M | $24.35M | $25.98M | $7.14M | $7.14M |
| Net income | $-60.51M | $-65.77M | $-63.69M | $-20.60M | $-23.25M |
| EPS | — | — | — | — | $-0.33 |
| Free cash flow | $-50.08M | $-63.63M | $-61.20M | $-97.98M | $-17.23M |
| Profit margin | -397.69% | -270.04% | -245.13% | -288.26% | -288.30% |
Peer comparison
Smart narrative
Whitehawk Therapeutics, Inc. trades at $4.04. Our Smart Value Score of 24/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $7.14M. with profit margins at -288.30%.
Frequently asked questions
What is Whitehawk Therapeutics, Inc.'s stock price?
Whitehawk Therapeutics, Inc. (WHWK) trades at $4.04.
Is Whitehawk Therapeutics, Inc. overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Whitehawk Therapeutics, Inc. (WHWK)?
The analyst target price is $6.25, representing +54.7% upside from the current price of $4.04.
What is Whitehawk Therapeutics, Inc.'s revenue?
TTM revenue is $7.14M.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio27.28x
ROE-21.80%
Beta0.62
50D MA$3.63
200D MA$2.57
Shares out0.05B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—